ArticleFrontiers in oncology2022

The COMT Genetic Factor Regulates Chemotherapy-Related Prospective Memory Impairment in Survivors With HER2-/+ Breast Cancer.

Wen Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.